A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2

Year of Publication:

Categories of Publication:

Lay Abstract and Manuscript Citation:

Flanigan KM, Vetter TA, Simmons TR, Iammarino M, Frair EC, Rinaldi F, Chicoine LG, Harris J, Cheatham JP, Cheatham SL, Boe B, Waldrop MA, Zygmunt DA, Packer D, Martin PT. A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2. Mol Ther Methods Clin Dev. 2022 Sep 2;27:47-60. doi: 10.1016/j.omtm.2022.08.009. PMID: 36186954; PMCID: PMC9483573

Find publication:

DOI: 10.1016/j.omtm.2022.08.009

The lay abstract for this publication was generated using an AI model and reviewed by the lead author and the PEDSnet Engagement Core team.

Scroll to Top